Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...

Medtronic has announced that the US Food and Drug Administration (FDA) has approved the Affera mapping and ablation system ...

The Texas Cardiac Arrhythmia Institute (TCAI) at St David's Medical Center has become the first clinic in the US to use Medtronic’s Affera mapping and ablation system with the Sphere-9 catheter ...

New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, Martha said Monday at the J.P. Morgan Healthcare Conference.

GALWAY, Ireland - Medtronic plc (NYSE:MDT), a global healthcare technology leader, announced today that it has received FDA approval for its Affera Mapping and Ablation System... ByInvesting.com ...

Moreover, Medtronic received FDA approval for its advanced Affera Mapping and Ablation System with Sphere-9 Catheter, designed for the treatment of persistent atrial fibrillation and cavotricuspid ...

Moreover, Medtronic received FDA approval for its advanced Affera Mapping and Ablation System with Sphere-9 Catheter, designed for the treatment of persistent atrial fibrillation and cavotricuspid ...

In other recent news, Medtronic has received FDA approval for its advanced Affera Mapping and Ablation System with Sphere-9 Catheter, designed for the treatment of persistent atrial fibrillation and ...